# Concept: entity00413046:AmortisationExpenseOfDisclosureOfOperatingSegmentsLineItemsOfDisclosureOfOperatingSegmentsTableOfItems

## Bilingual Labels
- **EN**: entity00413046:AmortisationExpenseOfDisclosureOfOperatingSegmentsLineItemsOfDisclosureOfOperatingSegmentsTableOfItems

- **ID**: entity00413046:AmortisationExpenseOfDisclosureOfOperatingSegmentsLineItemsOfDisclosureOfOperatingSegmentsTableOfItems
- **Note**: This is a company-specific extension, likely related to `ifrs-full:AmortisationExpense`.

## Reported Numerical Facts

### **Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member]**
<!-- Context (IDs): ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis: ifrs-full:ConsolidatedMember -->
- **Period: 2024-01-01 to 2024-03-31**
  - **Value**: 112,826,176,000 (decimals: -3)
- **Period: 2025-01-01 to 2025-03-31**
  - **Value**: 50,761,381,000 (decimals: -3)

### **Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member] and Segment consolidation items [axis]: entity00413046:BiopharmaceuticalMedicinesOfOperatingSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember**
<!-- Context (IDs): ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis: ifrs-full:ConsolidatedMember and ifrs-full:SegmentConsolidationItemsAxis: entity00413046:BiopharmaceuticalMedicinesOfOperatingSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember -->
- **Period: 2024-01-01 to 2024-03-31**
  - **Value**: 103,967,226,000 (decimals: -3)
- **Period: 2025-01-01 to 2025-03-31**
  - **Value**: 41,501,047,000 (decimals: -3)

### **Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member] and Segment consolidation items [axis]: entity00413046:ChemicalMedicinesOfOperatingSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember**
<!-- Context (IDs): ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis: ifrs-full:ConsolidatedMember and ifrs-full:SegmentConsolidationItemsAxis: entity00413046:ChemicalMedicinesOfOperatingSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember -->
- **Period: 2024-01-01 to 2024-03-31**
  - **Value**: 3,929,388,000 (decimals: -3)
- **Period: 2025-01-01 to 2025-03-31**
  - **Value**: 4,342,076,000 (decimals: -3)

### **Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member] and Segment consolidation items [axis]: All other segments [member]**
<!-- Context (IDs): ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis: ifrs-full:ConsolidatedMember and ifrs-full:SegmentConsolidationItemsAxis: ifrs-full:AllOtherSegmentsMember -->
- **Period: 2024-01-01 to 2024-03-31**
  - **Value**: 0 (decimals: -3)
- **Period: 2025-01-01 to 2025-03-31**
  - **Value**: 0 (decimals: -3)

### **Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member] and Segment consolidation items [axis]: Elimination of intersegment amounts [member]**
<!-- Context (IDs): ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis: ifrs-full:ConsolidatedMember and ifrs-full:SegmentConsolidationItemsAxis: ifrs-full:EliminationOfIntersegmentAmountsMember -->
- **Period: 2024-01-01 to 2024-03-31**
  - **Value**: 4,929,562,000 (decimals: -3)
- **Period: 2025-01-01 to 2025-03-31**
  - **Value**: 4,918,258,000 (decimals: -3)

---
*Source Document: entity00413046_2025-03-31.xbrl*
## Embeddable Text (for FAISS)
```text
Concept: entity00413046:AmortisationExpenseOfDisclosureOfOperatingSegmentsLineItemsOfDisclosureOfOperatingSegmentsTableOfItems
Bilingual Labels
 EN: entity00413046:AmortisationExpenseOfDisclosureOfOperatingSegmentsLineItemsOfDisclosureOfOperatingSegmentsTableOfItems
 ID: entity00413046:AmortisationExpenseOfDisclosureOfOperatingSegmentsLineItemsOfDisclosureOfOperatingSegmentsTableOfItems
 Note: This is a companyspecific extension, likely related to ifrsfull:AmortisationExpense.
Reported Numerical Facts
Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member]
<! Context (IDs): ifrsfull:ConsolidatedAndSeparateFinancialStatementsAxis: ifrsfull:ConsolidatedMember >
 Period: 20240101 to 20240331
   Value: 112,826,176,000 (decimals: 3)
 Period: 20250101 to 20250331
   Value: 50,761,381,000 (decimals: 3)
Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member] and Segment consolidation items [axis]: entity00413046:BiopharmaceuticalMedicinesOfOperatingSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember
<! Context (IDs): ifrsfull:ConsolidatedAndSeparateFinancialStatementsAxis: ifrsfull:ConsolidatedMember and ifrsfull:SegmentConsolidationItemsAxis: entity00413046:BiopharmaceuticalMedicinesOfOperatingSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember >
 Period: 20240101 to 20240331
   Value: 103,967,226,000 (decimals: 3)
 Period: 20250101 to 20250331
   Value: 41,501,047,000 (decimals: 3)
Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member] and Segment consolidation items [axis]: entity00413046:ChemicalMedicinesOfOperatingSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember
<! Context (IDs): ifrsfull:ConsolidatedAndSeparateFinancialStatementsAxis: ifrsfull:ConsolidatedMember and ifrsfull:SegmentConsolidationItemsAxis: entity00413046:ChemicalMedicinesOfOperatingSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember >
 Period: 20240101 to 20240331
   Value: 3,929,388,000 (decimals: 3)
 Period: 20250101 to 20250331
   Value: 4,342,076,000 (decimals: 3)
Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member] and Segment consolidation items [axis]: All other segments [member]
<! Context (IDs): ifrsfull:ConsolidatedAndSeparateFinancialStatementsAxis: ifrsfull:ConsolidatedMember and ifrsfull:SegmentConsolidationItemsAxis: ifrsfull:AllOtherSegmentsMember >
 Period: 20240101 to 20240331
   Value: 0 (decimals: 3)
 Period: 20250101 to 20250331
   Value: 0 (decimals: 3)
Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member] and Segment consolidation items [axis]: Elimination of intersegment amounts [member]
<! Context (IDs): ifrsfull:ConsolidatedAndSeparateFinancialStatementsAxis: ifrsfull:ConsolidatedMember and ifrsfull:SegmentConsolidationItemsAxis: ifrsfull:EliminationOfIntersegmentAmountsMember >
 Period: 20240101 to 20240331
   Value: 4,929,562,000 (decimals: 3)
 Period: 20250101 to 20250331
   Value: 4,918,258,000 (decimals: 3)
Source Document: entity00413046_20250331.xbrl
```